DOCSLIB.ORG

Amended Safety Assessment of Achillea Millefolium-Derived Ingredients As Used in Cosmetics

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Amended Safety Assessment of Achillea Millefolium-Derived Ingredients As Used in Cosmetics Amended Safety Assessment of Achillea Millefolium-Derived Ingredients as Used in Cosmetics Status: Tentative Amended Report for Public Review Release Date: June 21, 2013 Panel Meeting Date: September 9-10, 2013 All interested persons are provided 60 days from the above date to comment on this Tentative Safety Assessment and to identify additional published data that should be included or provide unpublished data which can be made public and included. Information may be submitted without identifying the source or the trade name of the cosmetic product containing the ingredient. All unpublished data submitted to CIR will be discussed in open meetings, will be available at the CIR office for review by any interested party and may be cited in a peer-reviewed scientific journal. Please submit data, comments, or requests to the CIR Director, Dr. F. Alan Andersen. The 2013 Cosmetic Ingredient Review Expert Panel members are: Chairman, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V. Belsito, M.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; Ronald A Hill, Ph.D. James G. Marks, Jr., M.D.; Ronald C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Director is F. Alan Andersen, Ph.D. This report was prepared by Lillian C. Becker, Scientific Analyst/Writer. © Cosmetic Ingredient Review 1101 17th Street, NW, Suite 412 Washington, DC 20036-4702 ph 202.331.0651 fax 202.331.0088 [email protected] i TABLE OF CONTENTS TABLE OF CONTENTS............................................................................................................................................................. ii ABSTRACT ................................................................................................................................................................................ 3 INTRODUCTION ....................................................................................................................................................................... 3 Original Safety Assessment ..................................................................................................................................................... 3 CHEMISTRY .............................................................................................................................................................................. 3 Definition ................................................................................................................................................................................ 3 Physical and Chemical Properties ........................................................................................................................................... 3 Constituents......................................................................................................................................................................... 4 Method of Manufacture ........................................................................................................................................................... 4 Impurities ................................................................................................................................................................................ 4 USE .............................................................................................................................................................................................. 4 TOXICOKINETICS .................................................................................................................................................................... 4 Absorption, Distribution, Metabolism, and Excretion ............................................................................................................. 4 Cytotoxicity ............................................................................................................................................................................. 5 TOXICOLOGICAL STUDIES ................................................................................................................................................... 5 Acute Toxicity ......................................................................................................................................................................... 5 Oral – Non-Human.............................................................................................................................................................. 5 Intraperitoneal ..................................................................................................................................................................... 5 Repeated Dose Toxicity .......................................................................................................................................................... 5 Oral – Non-Human.............................................................................................................................................................. 5 REPRODUCTIVE AND DEVELOPMENTAL TOXICITY ...................................................................................................... 5 GENOTOXICITY ....................................................................................................................................................................... 6 In Vitro .................................................................................................................................................................................... 6 IRRITATION AND SENSITIZATION ...................................................................................................................................... 6 Irritation ................................................................................................................................................................................... 6 Dermal – Non-Human ......................................................................................................................................................... 6 Ocular .................................................................................................................................................................................. 6 Sensitization ............................................................................................................................................................................ 6 Dermal – Non-Human ......................................................................................................................................................... 6 Dermal – Human ................................................................................................................................................................. 6 CLINICAL USE .......................................................................................................................................................................... 7 Case Studies ............................................................................................................................................................................ 7 SUMMARY ................................................................................................................................................................................. 7 DISCUSSION .............................................................................................................................................................................. 7 CONCLUSION............................................................................................................................................................................ 8 TABLES AND FIGURES ........................................................................................................................................................... 8 REFERENCES .......................................................................................................................................................................... 14 ii ABSTRACT Cosmetic ingredients derived from Achillea millefolium function in cosmetics as skin-conditioning agents – miscellaneous, skin-conditioning agents – humectants; and fragrance ingredients. The Panel reviewed relevant animal and human data to determine their safety in cosmetics. Because more than one botanical ingredient may be used in a formulation, caution was urged to avoid reaching levels of concern from an accumulation of toxicological and allergenic constituent chemicals and impurities such as pesticides. The CIR Expert Panel concluded that achillea millefolium extract, achillea millefolium flower extract, and achillea millefolium flower/leaf/stem extract are safe in the present practices of use and concentration in cosmetics. INTRODUCTION This is a tentative amended safety assessment of Achillea millefolium (yarrow)-derived ingredients. These ingredients function in cosmetics as skin-conditioning agents – miscellaneous, skin-conditioning agents – humectants; and fragrance ingredients. The three ingredients in this safety assessment are: • achillea millefolium extract, • achillea millefolium flower/leaf/stem extract, and • achillea millefolium flower extract. In 2001, the Cosmetic Ingredient Review (CIR) published a safety assessment of achillea millefolium extract as used in cosmetics.1 The CIR Expert Panel concluded that there were insufficient data to determine the
Load more

Recommended publications
  • (12) United States Patent (10) Patent No.: US 8,927.241 B2 Ajikumar Et Al
    USOO8927241B2 (12) United States Patent (10) Patent No.: US 8,927.241 B2 Ajikumar et al. (45) Date of Patent: *Jan. 6, 2015 (54) MICROBIAL ENGINEERING FOR THE 2010/0297722 A1 11/2010 Anterola et al. PRODUCTION OF CHEMICAL AND 38: i h S. A. s3. Fi Sharks et al. PHARMACEUTICAL PRODUCTS FROM THE Jikumar et al. ISOPRENOID PATHWAY FOREIGN PATENT DOCUMENTS (75) Inventors: Parayil K. Ajikumar, Cambridge, MA WO WO97,385.71 A1 10, 1997 (US); Gregory Stephanopoulos, Int (US); Too Heng Phon, OTHER PUBLICATIONS 73) Assi : M h Insti fTechnol Broun et al., Catalytic plasticity of fatty acid modification enzymes (73) SS1gnees: C s t it's R nology, underlying chemical diversity of plant lipids. Science, 1998, vol. 282: ambridge, ; Nationa 1315-1317. liversity of Singapore, Singapore Chica et al., Semi-rational approaches to engineering enzyme activ (SG) ity: combining the benefits of directed evolution and rational design. (*) Notice: Subject to any disclaimer, the term of this Curr. Opi. Biotechnol.-- 200 5, vol. 16. 378RSRRSRA 384. sk atent is extended or adjusted under 35 Devos et al., Practical limits of function prediction. Proteins: Struc p S.C. 154(b) by 354 days ture, Function, and Genetics. 2000, vol. 41: 98-107. M YW- y yS. Kisselev L., Polypeptide release factors in prokaryotes and This patent is Subject to a terminal dis- eukaryotes: same function, different structure. Structure, 2002, vol. claimer. 10:8-9. Seffernicket al., Melamine deaminase and Atrazine chlorohydrolase: (21) Appl. No.: 13/249,388 98 percent identical but functionally different. J. Bacteriol., 2001, vol. 183 (8): 2405-2410.* (22) Filed: Sep.
    [Show full text]
  • Astonishing Diversity of Natural Peroxides As Potential Therapeutic Agents Valery M Dembitsky* Institute of Drug Discovery, P.O
    a ular nd G ec en l e o t i M c f M o l e Journal of Molecular and Genetic d a i n c r i n u e o Dembitsky, J Mol Genet Med 2015, 9:1 J Medicine ISSN: 1747-0862 DOI: 10.4172/1747-0862.1000163 Review Article Open Access Astonishing Diversity of Natural Peroxides as Potential Therapeutic Agents Valery M Dembitsky* Institute of Drug Discovery, P.O. Box 45289, Jerusalem 91451, Israel *Corresponding author: Dembitsky VM, Institute of Drug Discovery, P.O. Box 45289, Jerusalem 91451, Israel, Tel: +972 526 877 444, E-mail: [email protected] Received date: January 28, 2015, Accepted date: February 25, 2015, Published date: March 04, 2015 Copyright: © 2015 Dembitsky VM. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Peroxides are an interesting group among biological active natural compounds. These metabolites contain a peroxide group (-O-O-) in which each oxygen atom is bonded to the other oxygen and to another atom. β-Oxygen in hydroperoxide group is considered as more active. Present review describes research on more than 230 natural peroxides isolated from plants, algae, and fungi. Intensive searches for new classes of biologically active metabolites produced by terrestrial and marine origin have resulted in the discovery of dozens of compounds possessing high antimalarial, antibacterial, cytotoxic, and other pharmacological activities as an important source of leads for drug discovery.
    [Show full text]
  • A Review of Botany, Phytochemical, and Pharmacological Effects of Dysphania Ambrosioides
    Indonesian Journal of Life Sciences Vol. 02 | Number 02 | September (2020) http://journal.i3l.ac.id/ojs/index.php/IJLS/ REVIEW ARTICLE A Review of Botany, Phytochemical, and Pharmacological Effects of Dysphania ambrosioides Lavisiony Gracius Hewis1, Giovanni Batista Christian Daeli1, Kenjiro Tanoto1, Carlos1, Agnes Anania Triavika Sahamastuti1* 1Pharmacy study program, Indonesia International Institute for Life-sciences, Jakarta, Indonesia *corresponding author. Email: [email protected] ABSTRACT Traditional medicine is widely used worldwide due to its benefits and healthier components that these natural herbs provide. Natural products are substances produced or retrieved from living organisms found in nature and often can exert biological or pharmacological activity, thus making them a potential alternative for synthetic drugs. Natural products, especially plant-derived products, have been known to possess many beneficial effects and are widely used for the treatment of various diseases and conditions. Dysphania ambrosioides is classified as an annual or short-lived perennial herb commonly found in Central and South America with a strong aroma and a hairy characteristic. Major components in this herb are ascaridole, p-cymene, α-terpinene, terpinolene, carvacrol, and trans-isoascaridole. Active compounds isolated from this herb are found to exert various pharmacological effects including schistosomicidal, nematicidal, antimalarial, antileishmanial, cytotoxic, antibacterial, antiviral, antifungal, antioxidant, anticancer, and antibiotic modulatory activity. This review summarizes the phytochemical compounds found in the Dysphania ambrosioides, together with their pharmacological and toxicological effects. Keywords: Dysphania ambrosioides; phytochemicals; pharmacological effect; secondary metabolites; toxicity INTRODUCTION pharmacologically-active compound, morphine, Natural products have been used by a wide was isolated from plants by Serturner spectrum of populations to alleviate and treat (Krishnamurti & Rao, 2016).
    [Show full text]
  • Thesis Style Document
    Application of Membrane Technologies in Water Purification Junjie Shen Submitted for the degree of Doctor of Philosophy Heriot-Watt University School of Engineering and Physical Sciences Institute of Chemical Sciences Edinburgh, United Kingdom May 2016 The copyright in this thesis is owned by the author. Any quotation from the thesis or use of any of the information contained in it must acknowledge this thesis as the source of the quotation or information. Abstract The world is facing a serious water crisis due to rapid population growth, industrialization and climate change. Water purification using membrane technologies provides a promising solution to address this problem. This thesis investigated the feasibility of membrane technologies in a wide range of applications covering drinking water purification and wastewater treatment. Target contaminants included fluoride, natural organic matter (NOM), emerging contaminants bisphenol A (BPA) and cimetidine, and the waterborne parasite Cryptosporidium. The first part of the thesis explored the solute- solute interactions of fluoride and humic substances (HS) in order to understand the behaviour of fluoride in natural water and during membrane filtration processes. It is shown that, at low pH and high ionic strength, fluoride ions are temporarily trapped inside the structure of HS aggregates. The second part of the thesis examined the feasibility of nanofiltration (NF) and reverse osmosis (RO) in treating challenging natural waters in Tanzania containing high fluoride and NOM concentrations, with the aim to increase the availability of drinking water sources. Fluoride retention was found to be dependent on ionic strength and recovery, which was predominantly due to a solution-diffusion mechanism.
    [Show full text]
  • Identification of Plant Derived Substances That Enhance Biodegradation of Polycyclic Aromatic Hydrocarbons in Soils
    Identification of Plant Derived Substances That Enhance Biodegradation of Polycyclic Aromatic Hydrocarbons In Soils David Crowley*, Haakrho Yi, Joong Wook Park, Ian Balcom, and Monica Winters Department of Environmental Sciences University of California, Riverside Phytoremediation Phytoextraction Rhizofiltration Phytostabilization Rhizoremediation Phytovolatilization Phytobial Remediation Plant Common Name Petroleum Hydrocarbons Mechanism of (Genus, Species ) [Family] Phytoremediation Western wheatgrass chrysene, benzo[a]pyrene, unknown (Agropyron smithii) benz[a]anthracene, dibenz[a,h]anthracene Big bluestem (Andropogon chrysene, benzo[a]pyrene, unknown gerardi) [Gramineae] benz[a]anthracene, dibenz[a,h]anthracene Side oats grama (Bouteloua chrysene, benzo[a]pyrene unknown curtipendula) benz[a]anthracene, dibenz[a,h]anthracene Blue grama (Bouteloua chrysene, benzo[a]pyrene, benz[a]anthracene, unknown gracilis) dibenz[a,h]anthracene Common buffalograss naphthalene, fluorene, phenanthrene unknown (Buchloe dactyloides) Prairie buffalograss naphthalene, fluorene, phenanthrene unknown (Buchloe dactyloides) Canada wild rye (Elymus chrysene, benzo[a]pyrene, benz[a]anthracene, unknown canadensis) dibenz[a,h]anthracene Red fescue (Festuca rubra crude oil and diesel rhizosphere effect var. Arctared) Poplar trees (Populus potential to phytoremediate benzene, toluene, rhizosphere effect deltoides x nigra) o-xylene Little bluestem chrysene, benzo[a]pyrene, benz[a]anthracene, unknown (Schizchyrium scoparious dibenz[a,h]anthracene Indiangrass (Sorghastrum
    [Show full text]
  • Plant Terpenes – Hongjie Zhang, Minghua Qiu, Yegao Chen, Jinxiong Chen, Yun Sun, Cuifang Wang, Harry H.S
    PHYTOCHEMISTRY AND PHARMACOGNOSY – Plant Terpenes – Hongjie Zhang, Minghua Qiu, Yegao Chen, Jinxiong Chen, Yun Sun, Cuifang Wang, Harry H.S. Fong PLANT TERPENES Hongjie Zhang Program for Collaborative Research in the Pharmaceutical Sciences, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, the University of Illinois at Chicago, Illinois 60612, USA Minghua Qiu State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650204 P. R. China Yegao Chen Department of Chemistry, Yunnan Normal University, Kunming 650092, P. R. China Jinxiong Chen, State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650204 P. R. China Yun Sun State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650204 P. R. China Cuifang Wang State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650204 P. R. China Harry H.S. Fong Program for Collaborative Research in the Pharmaceutical Sciences, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, the University of Illinois at Chicago, Illinois 60612, USA Keywords: Terpenes, Plants, Secondary Metabolites, Biological Activities, Biosynthetic Pathway. Contents 1. IntroductionUNESCO – EOLSS 2. Hemiterpenes 3. MonoterpenesSAMPLE CHAPTERS 4. Sesquiterpenes 5. Diterpenes 6. Sesterterpenes 7. Triterpenes 8. Polyterpenes 9. Conclusions Glossary Bibliography Biographical Sketch ©Encyclopedia of Life Support Systems (EOLSS) PHYTOCHEMISTRY AND PHARMACOGNOSY – Plant Terpenes – Hongjie Zhang, Minghua Qiu, Yegao Chen, Jinxiong Chen, Yun Sun, Cuifang Wang, Harry H.S. Fong Summary Terpenoids are hydrocarbon natural products based on five-carbon (isoprene) units as their building blocks, numbering more than 30,000 molecules having been discovered to-date.
    [Show full text]
  • Modes of Action of Herbal Medicines and Plant Secondary Metabolites
    Medicines 2015, 2, 251-286; doi:10.3390/medicines2030251 OPEN ACCESS medicines ISSN 2305-6320 www.mdpi.com/journal/medicines Review Modes of Action of Herbal Medicines and Plant Secondary Metabolites Michael Wink Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, INF 364, Heidelberg D-69120, Germany; E-Mail: [email protected]; Tel.: +49-6221-544-881; Fax: +49-6221-544-884 Academic Editor: Shufeng Zhou Received: 13 August 2015 / Accepted: 31 August 2015 / Published: 8 September 2015 Abstract: Plants produce a wide diversity of secondary metabolites (SM) which serve them as defense compounds against herbivores, and other plants and microbes, but also as signal compounds. In general, SM exhibit a wide array of biological and pharmacological properties. Because of this, some plants or products isolated from them have been and are still used to treat infections, health disorders or diseases. This review provides evidence that many SM have a broad spectrum of bioactivities. They often interact with the main targets in cells, such as proteins, biomembranes or nucleic acids. Whereas some SM appear to have been optimized on a few molecular targets, such as alkaloids on receptors of neurotransmitters, others (such as phenolics and terpenoids) are less specific and attack a multitude of proteins by building hydrogen, hydrophobic and ionic bonds, thus modulating their 3D structures and in consequence their bioactivities. The main modes of action are described for the major groups of common plant secondary metabolites. The multitarget activities of many SM can explain the medical application of complex extracts from medicinal plants for more health disorders which involve several targets.
    [Show full text]
  • Exploring Essential Oils As Prospective Therapy Against the Ravaging Coronavirus (SARS-Cov-2)
    IBEROAMERICAN JOURNAL OF MEDICINE 04 (2020) 322-330 Journal homepage: www.iberoamericanjm.tk Review Exploring essential oils as prospective therapy against the ravaging Coronavirus (SARS-CoV-2) Emmanuel Onah Ojaha,* aMedicinal Chemistry Research Group, Organic Chemistry Unit, Department of Chemistry, University of Ibadan, Ibadan, Nigeria ARTICLE INFO ABSTRACT Article history: Introduction: Aromatic plants produce diverse chemical constituents with potential to Received 09 June 2020 inhibit viral infections. These plants have been utilized for the prevention and treatment Received in revised form 16 June of a range of infectious and non-infectious diseases. Essential oils are among the plant- 2020 derived antiviral agents that are being employed in phytomedicine, and are considered as prospective drug candidate against the ravaging Coronavirus. Accepted 22 June 2020 Methods: Relevant articles relating to the concept were identified using a combination of manual library search as well as journal publication on the subject and critically Keywords: reviewed. Coronavirus Results: Essential oils in medicinal plants have extensive applications in medicinal Medicinal plants chemistry, aromatherapy and pharmaceuticals. Essential oils have several biological Essential oil properties such as antibacterial, antifungal, antiviral, antioxidant, anti-inflammatory, Aromatherapy wound-healing and anti-cancer effects in vitro and in vivo. Several reports have analyzed Antiviral and described essential oils as good antiviral agents against Respiratory tract viral infections hence are excellent prospective candidate against Corona virus. Conclusions: It is hoped that efficient and effective exploration and optimization of essential oils from medicinal plants would improve the drug discovery process against the ravaging Coronavirus. © 2020 The Authors. Published by Iberoamerican Journal of Medicine. This is an open access article under the CC BY license (http://creativecommons.
    [Show full text]
  • Status of Terpenes As Skin Penetration Enhancers
    Drug Discovery Today Volume 12, Numbers 23/24 December 2007 REVIEWS POST SCREEN Status of terpenes as skin penetration enhancers Reviews Mohammed Aqil, Abdul Ahad, Yasmin Sultana and Asgar Ali Department of Pharmaceutics, Faculty of Pharmacy, Hamdard University, New Delhi 110062, India Since its introduction, transdermal drug delivery has promised much but, in some respects has still to deliver on that initial promise, due to inherent limitations imposed by the percutaneous route. The greatest obstacle for transdermal delivery is the barrier property of the stratum corneum. Many approaches have been employed to breach the skin barrier, of which, the most widely used one is that of chemical penetration enhancers. Of the penetration enhancers, terpenes are arguably the most highly advanced and proven category and are classified as generally regarded as safe (GRAS) by the Food and Drug Administration. This paper presents an overview of the investigations on the feasibility and application of terpenes as sorption promoters for improved delivery of drugs through skin. Introduction As the name suggests, volatile oils or essential oils are volatile in Drug delivery via the percutaneous route potentially has many nature. They are widely used therapeutically, as inhalations (e.g. advantages over intravenous and oral administration [1] but eucalyptus oil), orally (e.g. peppermint oil), as mouthwashes and human skin is designed to be a barrier to the passage of molecules gargles (e.g. thymol). Also, many essential oils are used in aro- either from inside to out or vice versa [2]. The principal barrier to matherapy nowadays. Clove oil and thyme oil are used as anti- topical drug delivery is the stratum corneum, which poses a septics, owing to their high phenol content [12].
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Tinnitus
    Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Tinnitus Chemical Activity Count (+)-ALPHA-VINIFERIN 1 (+)-AROMOLINE 1 (+)-BORNYL-ISOVALERATE 1 (+)-CATECHIN 1 (+)-EUDESMA-4(14),7(11)-DIENE-3-ONE 1 (+)-HERNANDEZINE 2 (+)-ISOLARICIRESINOL 1 (+)-NORTRACHELOGENIN 1 (+)-PSEUDOEPHEDRINE 1 (+)-SYRINGARESINOL-DI-O-BETA-D-GLUCOSIDE 1 (+)-T-CADINOL 1 (-)-16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 (-)-ALPHA-BISABOLOL 1 (-)-ANABASINE 1 (-)-APOGLAZIOVINE 1 (-)-BETONICINE 1 (-)-BORNYL-CAFFEATE 1 (-)-BORNYL-FERULATE 1 (-)-BORNYL-P-COUMARATE 1 (-)-CANADINE 1 (-)-DICENTRINE 1 (-)-EPICATECHIN 2 (-)-EPIGALLOCATECHIN-GALLATE 1 (1'S)-1'-ACETOXYCHAVICOL-ACETATE 1 (E)-4-(3',4'-DIMETHOXYPHENYL)-BUT-3-EN-OL 1 1,7-BIS-(4-HYDROXYPHENYL)-1,4,6-HEPTATRIEN-3-ONE 1 1,8-CINEOLE 4 Chemical Activity Count 1-ETHYL-BETA-CARBOLINE 2 10-ACETOXY-8-HYDROXY-9-ISOBUTYLOXY-6-METHOXYTHYMOL 1 10-DEHYDROGINGERDIONE 1 10-GINGERDIONE 1 12-(4'-METHOXYPHENYL)-DAURICINE 1 12-METHOXYDIHYDROCOSTULONIDE 1 13',II8-BIAPIGENIN 1 13-HYDROXYLUPANINE 1 13-OXYINGENOL-ESTER 1 16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 16-HYDROXY-4,4,10,13-TETRAMETHYL-17-(4-METHYL-PENTYL)-HEXADECAHYDRO- 1 CYCLOPENTA[A]PHENANTHREN-3-ONE 16-HYDROXYINGENOL-ESTER 1 2'-O-GLYCOSYLVITEXIN 1 2-BETA,3BETA-27-TRIHYDROXYOLEAN-12-ENE-23,28-DICARBOXYLIC-ACID 1 2-METHYLBUT-3-ENE-2-OL 2 2-VINYL-4H-1,3-DITHIIN 1 20-DEOXYINGENOL-ESTER 1 22BETA-ESCIN 1 24-METHYLENE-CYCLOARTANOL 2 3,3'-DIMETHYLELLAGIC-ACID 1 3,4-DIMETHOXYTOLUENE 2 3,4-METHYLENE-DIOXYCINNAMIC-ACID-BORNYL-ESTER 1 3,4-SECOTRITERPENE-ACID-20-EPI-KOETJAPIC-ACID
    [Show full text]
  • (2) Patent Application Publication (10) Pub. No.: US 2012/0107893 A1 Ajikumar Et Al
    US 201201078.93A1 (19) United States (2) Patent Application Publication (10) Pub. No.: US 2012/0107893 A1 Ajikumar et al. (43) Pub. Date: May 3, 2012 (54) MICROBIAL ENGINEERING FOR THE Related U.S. Application Data PRODUCTION OF CHEMICAL AND PHARMACEUTICAL PRODUCTS FROM THE (63) Continuation-in-part of application No. 12/943,477, ISOPRENOID PATHWAY filed on Nov. 10, 2010. (60) Provisional application No. 61/280,877, filed on Nov. (75) Inventors: Parayil K. Ajikumar, Cambridge, 10, 2009, provisional application No. 61/388,543, MA (US); Gregory filed on Sep. 30, 2010. Stephanopoulos, Winchester, MA (US); Too Heng Phon, Kent Vale Publication Classification (SG) (51) Int. Cl. CI2P 5/00 (2006.01) (73) Assignee: Massachusetts Institute of (52) U.S. Cl. ........................................................ 435/166 Technolechnology CambridgeCambridge. MAUs,MA (US e. ABSTRACT (21) Appl. No.: 13/249,388 The invention relates to the production of one or more terpe noids through microbial engineering, and relates to the manu (22) Filed: Sep. 30, 2011 facture of products comprising terpenoids. Patent Application Publication May 3, 2012 Sheet 1 of 24 US 2012/0107893 A1 q1:bla *... *… ---- , ~~~~. &#x3x3&############# Patent Application Publication May 3, 2012 Sheet 2 of 24 US 2012/0107893 A1 3.3. §§§ Fig.2b Patent Application Publication May 3, 2012 Sheet 3 of 24 US 2012/0107893 A1 : Patent Application Publication May 3, 2012 Sheet 4 of 24 US 2012/0107893 A1 §. 8, ºp. 7. § so speechinchMEpplomg Patent Application Publication May 3, 2012 Sheet 5 of 24 US 2012/0107893 A1 33 ?×ך?zzzzzzzzzzzzzzzzzzzzzzzzzzzzzzz& §§§ 3. cquitéd Ratsge twº §§§§?*************???? ???????????????? Patent Application Publication May 3, 2012 Sheet 6 of 24 US 2012/0107893 A1 ---, £ºstseata £xpressiº &gto: § 3.
    [Show full text]
  • Challenge of Utilization Vegetal Extracts As Natural Plant Protection Products
    applied sciences Review Challenge of Utilization Vegetal Extracts as Natural Plant Protection Products Daniela Suteu 1,*, Lacramioara Rusu 2, Carmen Zaharia 1,* , Marinela Badeanu 3 and Gabriel Mihaita Daraban 1 1 “Cristofor Simionescu” Faculty of Chemical Engineering and Environmental Protection, “Gheorghe Asachi” Technical University of Iasi, 73A D.Mangeron Blvd., 700050 Iasi, Romania; [email protected] 2 Faculty of Engineering, “Vasile Alecsandri” University of Bacau, 157 Calea Mără¸se¸sti, 600115 Bacau, Romania; [email protected] 3 Faculty of Horticulture, “Ion Ionescu de la Brazi” University of Agricultural Sciences and Veterinary Medicine of Iasi, 3 Mihail Sadoveanu Street, 700490 Iasi, Romania; [email protected] * Correspondence: [email protected] (D.S.); [email protected] (C.Z.); Tel.: +40-232-278683 (ext. 2260) (D.S.); +40-232-278683 (ext. 2175) (C.Z.) Received: 22 November 2020; Accepted: 11 December 2020; Published: 14 December 2020 Abstract: Natural plant protection products (known as biopesticides), derived from natural materials (plants, bacterial strains, and certain minerals) that can be used to control pests, are an alternative to plant protection chemicals (known as pesticides) due to certain advantages: less toxic to humans and the environment, no release/leaching of harmful residues, and usually much specific to the target pests. This review focuses on the systematization of information highlighting the main advantages related to the natural plant protection products used, the extractive methods of obtaining them, their physical-chemical analysis methodology, the specific constituents responsible for their pesticide effects, the mechanisms of action, and methods for direct application on vegetable crops or on seeds stored in warehouses, in order to eliminate the adverse effects occurred in the case of plant protection chemicals use.
    [Show full text]